FAHT1_11 Health Technology Assessment

Faculty of Pharmacy
Spring 2022
Extent and Intensity
1/1/0. 3 credit(s). Type of Completion: k (colloquium).
Teacher(s)
PharmDr. Dominik Grega, Ph.D. (lecturer)
PharmDr. Lenka Součková, Ph.D. (lecturer)
PharmDr. Martin Višňanský, MBA, Ph.D. (lecturer)
Guaranteed by
PharmDr. Dominik Grega, Ph.D.
Department of Applied Pharmacy – Departments – Faculty of Pharmacy
Timetable
each even Friday 13:30–15:20 45-221
  • Timetable of Seminar Groups:
FAHT1_11/01: each even Friday 15:30–17:10 45-221, D. Grega, L. Součková, M. Višňanský
Course Enrolment Limitations
The course is only offered to the students of the study fields the course is directly associated with.

The capacity limit for the course is 20 student(s).
Current registration and enrolment status: enrolled: 2/20, only registered: 0/20
fields of study / plans the course is directly associated with
Course objectives
A theoretical framework for selected domains of HTA will be presented (medical efficacy and safety, economic evaluation, social, legal, institutional, ethical and organizational issues), complemented by real-world examples and case studies.
Learning outcomes
By completing the subject, students will acquire basic knowledge in the field of pharmacoeconomics, health technology assessment and health economics, with an emphasis on proposed EUnetHTA Core Model Methodology, HE/HTA Dissemination across various stakeholders, including an update of Clinical Practice Guidelines, PE/HTA Assessment & Appraisal Principles, Horizon Scanning Algorithms and Disinvestment Strategies.
Syllabus
  • 1. History of Health Economics (HE), Pharmacoeconomics (PE) and Health Technology Assessment (HTA); Importance, Principles and Practices of HE, PE and HTA, EU ‘Cross-border Healthcare’ Directive, EUnetHTA Core Model, HEOR Overview
  • 2. Clinical Research Program (RCTs) vs. RWE Data (Registries, Pharmacovigilance); Systematic Reviews in HE, PE and HTA
  • 3. Health Policy Analysis
  • 4. Economic Evaluation – Analyses in Healthcare
  • 5. Institutional Management and Budget Impact Assessment
  • Implementation of HE Outcomes into Clinical Practice, Dissemination and Transfer of knowledge in PE/HTA and HE
  • 6. Transferability of Data, Outcomes and Results, local adaptation of HEOR; Ethics, Social, Cultural and other soft-domains in HE, PE and HTA
  • 7. Managed Entry agreements, Coverage with Evidence Development, Payments by Results, Compassionate Use Programs, Compulsory Licensing, Google/Netflix Model in Healthcare
Literature
  • STRAUS, Sharon E., Paul GLASZIOU, W. Scott RICHARDSON and R. Brian HAYNES. Evidence-based medicine : how to practice and teach EBM. Edited by Reena Pattani - Areti Angeliki Veroniki. Fifth edition. Edinburgh: Elsevier, 2019, xii, 324. ISBN 9780702062964. info
  • Drummond, F. Michael, Sculpher, J. Mark, Claxton, Karl, Stoddart. Methods for the Economic Evaluation of Health Care Programmes. Oxford Medical Publications, 4th Edition, 2015. ISBN 978-0199665884. info
  • ANNEMANS, Lieven. Health economics for non-economists : an introduction to the concepts, methods and pitfalls of health economic evaluations. Gent: Academia Press, 2008, xiii, 106. ISBN 9789038212746. info
Teaching methods
Monologic (reading, lecture, briefing) Dialogic (discussion, interview, brainstorming) Workshops
Assessment methods
Colloquium
Language of instruction
English
Further Comments
Study Materials
The course can also be completed outside the examination period.
The course is taught annually.
The course is also listed under the following terms Spring 2023, Spring 2024, Spring 2025.
  • Enrolment Statistics (Spring 2022, recent)
  • Permalink: https://is.muni.cz/course/pharm/spring2022/FAHT1_11